Close
Digital Health & Ai Innovation summit 2026
APE 2026

Industry Updates

Mylan/Perrigo Clarification

Mylan N.V. (NASDAQ: MYL) today announced that it was asked by the Irish Takeover Panel to issue the following clarification and retraction in accordance with...

Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes R

Best Practices' Medical Affairs Consortium provides Medical Affairs leaders with a forum for sharing insights about the key challenges they face. The consortium has developed...

Physicians Advocacy Institute (“PAI”) Endorses the Fair Medical Audit Acts of 2015

Today, U.S. Representative George Holding of North Carolina introduced "The Fair Medical Audits Act of 2015." The Physician Advocacy Institute ("PAI") strongly endorses this legislation,...

Weight Watchers To Present At The Citi 2015 Global Consumer Conference

Weight Watchers International, Inc. (NYSE: WTW) today announced that Nicholas Hotchkin, Chief Financial Officer, will present at the Citi 2015 Global Consumer Conference in New...

Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR

Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S. Court of Appeals for the Second Circuit has issued a ruling upholding a...

Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth

The U.S. Food and Drug Administration's (FDA) recent approval of Zarxio (filgrastim-sndz) -- the first biosimilar product approved in the United States -- points toward...

Nevro Announces First Commercial Procedure of HF10™ Therapy in the United States

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »